CClinicalTrials.gg
CompletedNCT01885975Updated Feb 16, 2015

Personality Profile of Patients With Apical Ballooning Syndrome

An observational study in Apical Ballooning Syndrome, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-02-16.

Sponsored by Mayo Clinic · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
53
Ages
18 Years and older
Sex
All
01

Study summary

The investigators' hypothesis is that patients with apical ballooning syndrome (ABS) will manifest a personality profile that differs than that of a population of similar range of ethnic and socioeconomic status.

02

Conditions studied

  • Apical Ballooning Syndrome

Keywords

  • Apical Ballooning syndrome
  • Personality
03

In context

Takotsubo Cardiomyopathy

61 studies on the registry are indexed under Takotsubo Cardiomyopathy; 25 are open to participants now.

This study's enrollment of 53 is below the median of 270 across 38 observational studies indexed under Takotsubo Cardiomyopathy.

Browse Takotsubo Cardiomyopathy studies →

Lead sponsor

Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.

Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This study will be conducted among participants in the Mayo Clinic Apical Ballooning Registry. These patients were prospectively diagnosed with Apical Ballooning Syndrome at the time of presentation with their acute illness, and consented to participation in a registry. They are residents of Olmsted County, and the surrounding regions for which the Mayo Clinic serves as a tertiary care center. Enrollment in the registry requires satisfaction of standard criteria for the diagnosis of ABS and includes the administration of a standardized questionnaire. Subjects have agreed to participate in yearly follow up questionnaires about their health status.

Inclusion criteria

  1. Patients who have suffered with ABS
  2. Adults (18 years or older)
  3. Able to read English at a 6th grade level (questionnaires are self-administered and written in English)

Exclusion criteria

Exclusion criteria:

  1. Have withdrawn from the registry
  2. Have died
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
53 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Range of personality traits as assessed by the "NEO-PI-3"

    The "NEO PI-3" measures the five major domains of personality, which are: * Neuroticism * Extraversion * Openness * Agreeableness * Conscientiousness

    Time frame: Baseline: the traits will be assessed once upon enrollment into the study

07

Study locations

1 site
  • Mayo Clinic in Rochester
    Rochester, Minnesota 55905, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 16, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01885975
Lead sponsor
Mayo Clinic
Responsible party
Abhiram Prasad (PI, Mayo Clinic) — Principal investigator
First posted
Jun 25, 2013
Start date
Jul 2013
Primary completion
Sep 2014
Completion
Sep 2014
Last update
Feb 16, 2015

Study contacts

Abhiram Prasad, MD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion